| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |